NPPB and chronic obstructive pulmonary disease: In the first survey [20], LV dysfunction burden was concentrated in COPD patients classified as GOLD III and IV (70%), with a significant proportion of subjects with documented ischemic heart disease (40.5%) and with a median value of NT-proBNP higher than that detected in our COPD population (677 vs. 115 pg/ml).